Skip to main content
. Author manuscript; available in PMC: 2014 Jul 25.
Published in final edited form as: Expert Rev Mol Diagn. 2013 Jul;13(6):567–580. doi: 10.1586/14737159.2013.819216

Figure 1. Monocyte and macrophage subsets.

Figure 1

Monocytes and macrophages are generally divided into two subsets that represent different expression patterns of surface markers and functions. Monocytes are divided into Ly6Chi/CD14hiCD16 monocytes (50% in mice and 90% in humans, respectively) and Ly6Clow/CD14+CD16+ monocytes (50% in mice and 10% in humans, respectively). Ly6Chi/CD14hiCD16 monocytes are characterized by expression of CCR2, which allows for trafficking of the monocytes towards inflamed tissues. Ly6Clow/CD14+CD16+ monocytes lack CCR2 but express CCR5 instead. It is not known if one of these subsets specifically matures into one of the two major macrophage subsets. M1 macrophages are known as inflammatory macrophages. They produce inflammatory cytokines and reactive oxygen species. They primarily stimulate the Th1 response and are involved in tissue destruction in many inflammatory diseases. M2 macrophages are described as anti-inflammatory or regulatory macrophages. They produce IL-10 to dampen local inflammation and are mainly involved in the Th2 response and chronic diseases. Their ability to produce tissue remodeling factors makes them valuable in the remodeling and regeneration of tissue. However, their functions are also a cause of unwanted tolerance in cancer.